WHO Drug Information Vol. 18, No. 2, 2004 - World Health ...
WHO Drug Information Vol. 18, No. 2, 2004 - World Health ...
WHO Drug Information Vol. 18, No. 2, 2004 - World Health ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>WHO</strong> <strong>Drug</strong> <strong>Information</strong>, <strong>Vol</strong>. <strong>18</strong>, <strong>No</strong>. 2, <strong>2004</strong> Proposed INN: List 91<br />
C24H28N2O3<br />
HO<br />
H<br />
OH<br />
H<br />
N<br />
312753-06-3<br />
indibulinum<br />
indibulin 2-[1-(4-chlorophenylmethyl)-1H-indol-3-yl]-2-oxo-N-(pyridin-<br />
4-yl)acetamide<br />
antineoplastic agent<br />
HN<br />
indibuline 2-[1-(4-chlorobenzyl)-1H-indol-3-yl]-2-oxo-N-(pyridin-4-yl)acétamide<br />
antinéoplasique<br />
indibulina 2-[1-(4-clorobencil)-1H-indol-3-il]-2-oxo-N-(piridin-4-il)acetamida<br />
antineoplásico<br />
O<br />
C22H16ClN3O2<br />
Cl<br />
N<br />
O<br />
O<br />
H<br />
N<br />
CH 3<br />
N<br />
CH 3<br />
204205-90-3<br />
ismomultinum alfa<br />
ismomultin alfa 47-261-Glycoprotein gp 39 (human clone CDM8-gp39 reduced)<br />
antirheumatic<br />
ismomultine alfa [290-isoleucine]glycoprotéine 39 constituant du cartilage humain<br />
(glycoforme alfa)<br />
antirhumatismal<br />
ismomultina alfa fragmento 47-261 de la glicoproteina 39 constituyente del cartílago<br />
humano (variante [Arg 124 ] producida por el clon humano CDM8gp39)<br />
antirreumático<br />
169
Change language